Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v7-FR | Version v5-EN | |
|---|---|---|
| Language | French | English |
| Date Updated | 2021-05-04 | 2021-04-30 |
| Drug Identification Number | 02453835 | 02453835 |
| Brand name | PRALUENT | PRALUENT |
| Common or Proper name | Praluent | Praluent |
| Company Name | SANOFI-AVENTIS CANADA INC | SANOFI-AVENTIS CANADA INC |
| Ingredients | ALIROCUMAB | ALIROCUMAB |
| Strength(s) | 150MG | 150MG |
| Dosage form(s) | SOLUTION | SOLUTION |
| Route of administration | SUBCUTANEOUS SUBCUTANEOUS | SUBCUTANEOUS SUBCUTANEOUS |
| Packaging size | 2 | 2 |
| ATC code | C10AX | C10AX |
| ATC description | LIPID MODIFYING AGENTS, PLAIN | LIPID MODIFYING AGENTS, PLAIN |
| Reason for shortage | Other (Please describe in comments) | Other (Please describe in comments) |
| Anticipated start date | 2021-04-29 | 2021-04-29 |
| Actual start date | ||
| Estimated end date | 2021-05-14 | 2021-05-14 |
| Actual end date | 2021-05-03 | |
| Shortage status | Resolved | Actual shortage |
| Tier 3 Status | No | No |
| Company comments | A manufacturing delay may create a short term shortage. Supplies are expected by early May, shortage should be avoided as allocation will be put in place. | A manufacturing delay may create a short term shortage. Supplies are expected by early May, shortage should be avoided as allocation will be put in place. |
| Health Canada comments |